The interferon signature in autoimmune diseases : Current Opinion in Rheumatology The
interferon signature in autoimmune diseases : Current Opinion in Rheumatology Log in or …

RA is a complex disease that develops as a series of events often referred to as disease
continuum. RA would benefit from novel biomarker development for diagnosis where new …

Tumor necrosis factor (TNF) is a key driver of several inflammatory diseases, such as
rheumatoid arthritis, inflammatory bowel disease, and psoriasis, in which affected tissues …

Mammals have developed evolutionarily conserved programs of transcriptional response to
hypoxia and inflammation. These stimuli commonly occur together in vivo and there is …

Background Type I interferons (IFN-I) contribute to a broad range of rheumatic and
musculoskeletal diseases (RMDs). Compelling evidence suggests that the measurement of …

Immune-mediated inflammatory diseases (IMIDs), such as spondyloarthritis (SpA), psoriasis,
Crohn's disease (CD), and rheumatoid arthritis (RA) remain challenging illnesses. They …

Biotechnological monoclonal antibodies and receptor antagonists capable of targeting
specific inflammatory actors, such as cytokines, cytokines receptors, co-stimulatory …

The pathogenesis of inflammatory bowel disease (IBD) is still unclear, but includes both
inflammatory and autoimmune reactions. Current methodological approaches could better …

Objective Anti–tumor necrosis factor (anti‐TNF) agents are successful therapies in
rheumatoid arthritis (RA); however, inadequate response occurs in 30–40% of patients …

Objective To analyze the relationship between the type I interferon (IFN) signature and
clinical response to rituximab in rheumatoid arthritis (RA) patients. Methods Twenty RA …